原发肺癌与配对转移灶中ALK基因重排与蛋白表达的比较
FISH与IHC总体一致率88%,IHC特异性100%、敏感性71%;原发灶与转移灶间ALK FISH一致率88%,IHC一致率94%,共5例不一致(15%)。结论提示FISH在原发与转移灶间的不一致更常见,可能与技术和样本质量有关。
要点
- ALK IHC与原发/转移灶一致性高于FISH,IHC特异性100%、敏感性71%。
- 原发与转移灶ALK FISH一致率88%,ALK IHC一致率94%。
- FISH不一致病例多因阳性细胞比例低,提示样本质量影响结果。
核心结论
- ALK FISH在原发与配对转移灶间的不一致较ALK IHC更常见。
- 不一致可能与技术挑战和样本质量有关。
- 样本质量和实验室技术能力应指导临床ALK检测决策。
研究设计与样本
- 回顾性收集15例ALK FISH重排和19例非ALK FISH重排腺癌。
- 采用Vysis ALK break-apart FISH kit和Ventana ALK D5F3 CDx assay检测。
主要发现
- FISH与IHC总体一致率88%,IHC特异性100%、敏感性71%。
- 原发灶与转移灶ALK FISH一致率88%(30例),ALK IHC一致率94%(32例)。
- 共5例不一致(15%)。
- 3例FISH不一致病例的FISH阳性肿瘤细胞比例低(平均23%,范围18-31%),且IHC均阴性。
- 1例IHC不一致病例FISH阳性细胞比例高(67%),但IHC阴性。
临床怎么用
- 临床ALK检测选择原发灶或转移灶时需考虑样本质量和技术因素。
- ALK IHC可作为与FISH互补的检测手段,但需注意其敏感性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The 2013 College of American Pathologists, the Association for Molecular Pathology and the International Association for the Study of Lung Cancer guideline for EGFR and ALK testing in lung carcinoma indicates that either the primary tumour or the metastasis is suitable for testing. The heterogeneity of gene mutations has been studied extensively, while similar reports on gene rearrangements are limited. The aim of this study was to determine if ALK status between primary tumour and matched metastasis differs. METHODS AND RESULTS: Fifteen ALK fluorescence in-situ hybridization (FISH) rearranged and 19 non-ALK FISH rearranged adenocarcinomas were collected retrospectively based on availability of tissue from a matched metastatic site. Sixty-eight samples were tested by ALK FISH (Vysis ALK break-apart FISH kit) and ALK immunohistochemistry (IHC) (Ventana ALK D5F3 CDx assay). Overall agreement of FISH and IHC was 88%, with IHC showing 100% specificity and 71% sensitivity. Concordance between primary site and metastasis by ALK FISH was seen in 30 cases (88%), and in 32 cases (94%) by ALK IHC. Five discordant cases were found (15%). Three ALK FISH discordant cases had low percentage of ALK FISH-positive tumour cells (average 23%, range: 18-31%) and all were negative by ALK IHC. One IHC discordant case had a high percentage of ALK FISH-positive tumour cells (67%), and was ALK IHC-negative. One FISH discordant case showed ALK FISH- and ALK IHC-positive primary tumour, but ALK FISH- and ALK IHC-negative metastasis. CONCLUSIONS: ALK FISH results show more frequent discordances between primary tumour and matched metastases than ALK IHC, due probably to technical challenges and sample quality. This observation indicates that the quality of sample and technical expertise of the laboratory should guide the decision about ALK testing in clinical practice.
引用
- Trejo Bittar HE, Luvison A, Miller C, et al. A comparison of ALK gene rearrangement and ALK protein expression in primary lung carcinoma and matched metastasis. Histopathology. 2017. PMID: 28316074. doi:10.1111/his.13215
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。